
Cbus Super Fund is a leading Australian superannuation fund with over $80 billion in assets under management.
The fund offers a range of investment options, including growth, balanced, and conservative portfolios, as well as a range of specialty funds.
Cbus has a strong track record of delivering returns to its members, with a 10-year average annual return of 7.3% as of 2022.
Investing in Cbus can be a smart move for your super, especially if you're looking for a fund that prioritizes member outcomes.
See what others are reading: Medallion Fund Stock
Company Information
Cibus, Inc. is a agricultural biotechnology company based in San Diego, California. The company was founded by Rory Riggs.
Cibus, Inc. has a significant presence in the agricultural industry, with 183 employees working for the company.
The company's CEO is Rory Riggs, who is leading the company's efforts in developing and licensing plant traits to seed companies for royalties.
Cibus, Inc. is primarily focused on trait productivity in two areas: productivity traits that enable farmers to have higher yields and reduce the use of crop protection chemicals and fertilizers, and sustainable ingredients that enable corporations to replace fossil fuel-based ingredients.
The company's website is www.cibus.com, where you can find more information about their products and services.
Here is a summary of the company's key information:
Financial Data

Cibus's revenue in 2023 was a significant $1.82 million, a massive 1057.32% increase from the previous year's $157,000.
The company's financial performance also saw a substantial loss of -$267.63 million in 2023, which is 1484.4% more than the loss in 2022.
Financial Performance
Cibus's revenue in 2023 was a significant $1.82 million, a staggering 1057.32% increase from the previous year's $157,000.
This growth is a testament to the company's ability to expand its operations and attract more customers.
Losses, however, were substantial, reaching -$267.63 million, a 1484.4% increase from the previous year.
Price History & Performance
Cibus's share price has fluctuated significantly over the past year, with a 52 Week High of $23.18 and a 52 Week Low of $2.17.
The company's current share price is $2.47, which represents a 1 Month Change of -20.32% and a 3 Month Change of -44.74%.
Its 1 Year Change is -$85.96%, and its 3 Year Change is -$96.57%.
The company's 5 Year Change is -$99.19%, and its Change since IPO is -$99.56%.
Here's a breakdown of Cibus's price history:
Johnson Fistel Investigates Short Report
Johnson Fistel is investigating potential securities law violations by Cibus, Inc. (NASDAQ: CBUS) following a short report.
Johnson Fistel, LLP is a shareholder rights law firm based in San Diego.
Johnson Fistel is looking into whether Cibus complied with federal securities laws.
Cibus, Inc. is a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties.
Cibus is listed on the Nasdaq stock exchange under the ticker symbol CBUS.
On June 5, 2024, Block & Leviton also announced an investigation into Cibus for potential securities law violations.
Investors who have lost money in their Cibus investment should consider speaking with a lawyer.
Holzer & Holzer, LLC is also investigating Cibus, Inc. to determine if the company complied with federal securities laws.
Glancy Prongay & Murray LLP commenced an investigation on behalf of Cibus, Inc. shareholders on June 5, 2024.
You might like: Blackrock Ticker Symbol
Events and Conferences
Cibus participates in the Sidoti Micro Cap Conference, where Co-Founders Rory Riggs and Peter Beetham will present on January 23, 2025, at 1:45 p.m. ET.
The company's breakthroughs in its proprietary RTDS gene editing process have enabled trait development in customers' elite germplasm within 12 months, with standardization for traits in Rice and Canola.
Cibus will also participate in the 13th Annual Roth Technology Conference, where Rory Riggs will represent the company on November 19-20, 2024, in New York City.
Attendees interested in meeting with Cibus representatives can arrange appointments through their conference host representative or directly with the company.
Attend Sidoti Micro Cap Conference
Attend the Sidoti Micro Cap Conference to learn about Cibus' groundbreaking gene editing technologies. The conference will take place on Thursday, January 23, 2025, at 1:45 p.m. ET.
Cibus' Co-Founders, Rory Riggs and Peter Beetham, will be presenting at the conference. Their presentation will be accessible via webcast to registered participants.
You can register to attend the conference and hear Cibus' innovative approach to seed trait development firsthand.
13th Annual Roth Technology Conference
The 13th Annual Roth Technology Conference is taking place in New York City on November 19-20, 2024. This event is a great opportunity for attendees to meet with industry professionals and learn about the latest developments in the field.
Cibus, an agricultural technology company, has announced its participation in the conference. Rory Riggs, Co-Founder, CEO, and Chairman of Cibus, will represent the company at the event.
Frequently Asked Questions
What is the price target for Cibus?
The average price target for Cibus is $16.33, based on 3 analyst forecasts. Analysts predict a range of $4.00 to $25.00 over the next 12 months.
Featured Images: pexels.com